Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileAnne Marie Lane, M.P.H.

TitleLecturer on Ophthalmology
InstitutionMassachusetts Eye and Ear Infirmary
DepartmentOphthalmology
AddressMassachusetts Eye & Ear Infrm
Retina Service
243 Charles St
Boston MA 02114
Phone617/573-3735
Fax617/573-3514
vCardDownload vCard (login for email)

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Johnson CP, Kim IK, Esmaeli B, Amin-Mansour A, Treacy DJ, Carter SL, Hodis E, Wagle N, Seepo S, Yu X, Lane AM, Gragoudas ES, Vazquez F, Nickerson E, Cibulskis K, McKenna A, Gabriel SB, Getz G, Van Allen EM, 't Hoen PAC, Garraway LA, Woodman SE. Systematic genomic and translational efficiency studies of uveal melanoma. PLoS One. 2017; 12(6):e0178189. PMID: 28594900.
    View in: PubMed
  2. Kim IK, Lane AM, Jain P, Awh C, Gragoudas ES. Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma. Trans Am Ophthalmol Soc. 2016 Aug; 114:T2. PMID: 27630373.
    View in: PubMed
  3. Lane AM, Kim IK, Gragoudas ES. Long-term Risk of Melanoma-Related Mortality After Uveal Melanoma--Reply. JAMA Ophthalmol. 2016 Feb; 134(2):239-40. PMID: 26720744.
    View in: PubMed
  4. Jardeleza MS, Rheaume MA, Chodosh J, Lane AM, Dohlman CH. Retinal detachments after Boston Keratoprosthesis: incidence, predisposing factors, and visual outcomes. Digit J Ophthalmol. 2015; 21(4):1-15. PMID: 27330474; PMCID: PMC4902639.
  5. Patel AV, Lane AM, Morrison MA, Trofimov AV, Shih HA, Gragoudas ES, Kim IK. Visual Outcomes after Proton Beam Irradiation for Choroidal Melanomas Involving the Fovea. Ophthalmology. 2016 Feb; 123(2):369-77. PMID: 26545316.
    View in: PubMed
  6. Gupta MP, Lane AM, DeAngelis MM, Mayne K, Crabtree M, Gragoudas ES, Kim IK. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations. JAMA Ophthalmol. 2015 Aug; 133(8):881-7. PMID: 25974357.
    View in: PubMed
  7. Lane AM, Kim IK, Gragoudas ES. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy. JAMA Ophthalmol. 2015 Jul; 133(7):792-6. PMID: 25905597.
    View in: PubMed
  8. Kamran SC, Collier JM, Lane AM, Kim I, Niemierko A, Chen YL, MacDonald SM, Munzenrider JE, Gragoudas E, Shih HA. Outcomes of proton therapy for the treatment of uveal metastases. Int J Radiat Oncol Biol Phys. 2014 Dec 01; 90(5):1044-50. PMID: 25442038.
    View in: PubMed
  9. Awh CC, Lane AM, Hawken S, Zanke B, Kim IK. Author reply: To PMID 23972322. Ophthalmology. 2014 Aug; 121(8):e39. PMID: 24793507.
    View in: PubMed
  10. Kloek CE, Borboli-Gerogiannis S, Chang K, Kuperwaser M, Newman LR, Lane AM, Loewenstein JI. A broadly applicable surgical teaching method: evaluation of a stepwise introduction to cataract surgery. J Surg Educ. 2014 Mar-Apr; 71(2):169-75. PMID: 24602704.
    View in: PubMed
  11. Awh CC, Lane AM, Hawken S, Zanke B, Kim IK. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. Ophthalmology. 2013 Nov; 120(11):2317-23. PMID: 23972322.
    View in: PubMed
  12. Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One. 2012; 7(4):e35295. PMID: 22545102; PMCID: PMC3335872.
  13. Lane AM, Kim IK, Gragoudas ES. Proton irradiation for peripapillary and parapapillary melanomas. Arch Ophthalmol. 2011 Sep; 129(9):1127-30. PMID: 21911661.
    View in: PubMed
  14. Vavvas D, Kim I, Lane AM, Chaglassian A, Mukai S, Gragoudas E. Posterior uveal melanoma in young patients treated with proton beam therapy. Retina. 2010 Sep; 30(8):1267-71. PMID: 20224468.
    View in: PubMed
  15. Lane AM, Egan KM, Kim IK, Gragoudas ES. Mortality after diagnosis of small melanocytic lesions of the choroid. Arch Ophthalmol. 2010 Aug; 128(8):996-1000. PMID: 20696999.
    View in: PubMed
  16. Kim IK, Lane AM, Gragoudas ES. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma. Arch Ophthalmol. 2010 Jul; 128(7):871-5. PMID: 20625048.
    View in: PubMed
  17. Marucci L, Ancukiewicz M, Lane AM, Collier JM, Gragoudas ES, Munzenrider JE. Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):842-6. PMID: 20472356.
    View in: PubMed
  18. Kim IK, Lane AM, Egan KM, Munzenrider J, Gragoudas ES. Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma. Ophthalmology. 2010 Aug; 117(8):1617-22. PMID: 20363507.
    View in: PubMed
  19. Henderson BA, Kim JY, Golnik KC, Oetting TA, Lee AG, Volpe NJ, Aaron M, Uhler TA, Arnold A, Dunn JP, Prajna NV, Lane AM, Loewenstein JI. Evaluation of the virtual mentor cataract training program. Ophthalmology. 2010 Feb; 117(2):253-8. PMID: 19969355.
    View in: PubMed
  20. Chan RV, Yonekawa Y, Lane AM, Skondra D, Munzenrider JE, Collier JM, Gragoudas ES, Kim IK. Proton beam irradiation using a light-field technique for the treatment of choroidal hemangiomas. Ophthalmologica. 2010; 224(4):209-16. PMID: 19940527.
    View in: PubMed
  21. Lane AM, Egan KM, Harmon D, Holbrook A, Munzenrider JE, Gragoudas ES. Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis. Ophthalmology. 2009 Nov; 116(11):2206-12. PMID: 19744725.
    View in: PubMed
  22. Kim IK, Ji F, Morrison MA, Adams S, Zhang Q, Lane AM, Capone A, Dryja TP, Ott J, Miller JW, DeAngelis MM. Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration. Mol Vis. 2008 Aug 11; 14:1487-95. PMID: 18704199; PMCID: PMC2515825.
  23. Zambarakji HJ, Lane AM, Ezra E, Gauthier D, Goitein M, Adams JA, Munzenrider JE, Miller JW, Gragoudas ES. Proton beam irradiation for neovascular age-related macular degeneration. Ophthalmology. 2006 Nov; 113(11):2012-9. PMID: 16935343.
    View in: PubMed
  24. Ament CS, Zacks DN, Lane AM, Krzystolik M, D'Amico DJ, Mukai S, Young LH, Loewenstein J, Arroyo J, Miller JW. Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture. Arch Ophthalmol. 2006 Jul; 124(7):957-66. PMID: 16832018.
    View in: PubMed
  25. Zambarakji HJ, Nakazawa T, Connolly E, Lane AM, Mallemadugula S, Kaplan M, Michaud N, Hafezi-Moghadam A, Gragoudas ES, Miller JW. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2006 Jun; 47(6):2623-31. PMID: 16723479.
    View in: PubMed
  26. Marucci L, Lane AM, Li W, Egan KM, Gragoudas ES, Adams JA, Collier JM, Munzenrider JE. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma. Int J Radiat Oncol Biol Phys. 2006 Mar 15; 64(4):1018-22. PMID: 16376492.
    View in: PubMed
  27. Kim IK, Husain D, Michaud N, Connolly E, Lane AM, Durrani K, Hafezi-Moghadam A, Gragoudas ES, O'Neill CA, Beyer JC, Miller JW. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid. Invest Ophthalmol Vis Sci. 2006 Jan; 47(1):357-63. PMID: 16384985.
    View in: PubMed
  28. Husain D, Kim I, Gauthier D, Lane AM, Tsilimbaris MK, Ezra E, Connolly EJ, Michaud N, Gragoudas ES, O'Neill CA, Beyer JC, Miller JW. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey. Arch Ophthalmol. 2005 Apr; 123(4):509-16. PMID: 15824225.
    View in: PubMed
  29. Tsina EK, Lane AM, Zacks DN, Munzenrider JE, Collier JM, Gragoudas ES. Treatment of metastatic tumors of the choroid with proton beam irradiation. Ophthalmology. 2005 Feb; 112(2):337-43. PMID: 15691572.
    View in: PubMed
  30. DeAngelis MM, Lane AM, Shah CP, Ott J, Dryja TP, Miller JW. Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration. Arch Ophthalmol. 2004 Apr; 122(4):575-80. PMID: 15078676.
    View in: PubMed
  31. Gragoudas E, Li W, Goitein M, Lane AM, Munzenrider JE, Egan KM. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol. 2002 Dec; 120(12):1665-71. PMID: 12470140.
    View in: PubMed
  32. Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Li W. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc. 2002; 100:43-8; discussion 48-9. PMID: 12545676; PMCID: PMC1358945.
  33. Rich D, Lane AM, Miller JW. Photodynamic therapy: the nurse's role. Insight. 2001 Apr; 26(2):44-8. PMID: 11426204.
    View in: PubMed
  34. Gragoudas ES, Lane AM, Regan S, Li W, Judge HE, Munzenrider JE, Seddon JM, Egan KM. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000 Jun; 118(6):773-8. PMID: 10865313.
    View in: PubMed
  35. Sickenberg M, Schmidt-Erfurth U, Miller JW, Pournaras CJ, Zografos L, Piguet B, Donati G, Laqua H, Barbazetto I, Gragoudas ES, Lane AM, Birngruber R, van den Bergh H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol. 2000 Mar; 118(3):327-36. PMID: 10721954.
    View in: PubMed
  36. Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol. 1999 Sep; 117(9):1177-87. PMID: 10496389.
    View in: PubMed
  37. Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, Zografos L, Piguet B, Donati G, Lane AM, Birngruber R, van den Berg H, Strong A, Manjuris U, Gray T, Fsadni M, Bressler NM, Gragoudas ES. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol. 1999 Sep; 117(9):1161-73. PMID: 10496388.
    View in: PubMed
  38. Gragoudas ES, Li W, Lane AM, Munzenrider J, Egan KM. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology. 1999 Aug; 106(8):1571-7; discussion 1577-8. PMID: 10442906.
    View in: PubMed
  39. Schmidt-Erfurth U, Miller J, Sickenberg M, Bunse A, Laqua H, Gragoudas E, Zografos L, Birngruber R, van den Bergh H, Strong A, Manjuris U, Fsadni M, Lane AM, Piguet B, Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol. 1998 May; 236(5):365-74. PMID: 9602321.
    View in: PubMed
  40. Lane AM, Egan KM, Yang J, Saornil MA, Alroy J, Albert D, Gragoudas ES. An evaluation of tumour vascularity as a prognostic indicator in uveal melanoma. Melanoma Res. 1997 Jun; 7(3):237-42. PMID: 9195563.
    View in: PubMed
  41. Friedman E, Krupsky S, Lane AM, Oak SS, Friedman ES, Egan K, Gragoudas ES. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology. 1995 Apr; 102(4):640-6. PMID: 7724181.
    View in: PubMed
  42. Adams MM, Scherr PA, Branch LG, Hebert LE, Cook NR, Lane AM, Brock DB, Evans DA, Taylor JO. A comparison of elderly participants in a community survey with nonparticipants. Public Health Rep. 1990 Nov-Dec; 105(6):617-22. PMID: 2124361; PMCID: PMC1580178.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Lane's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_